SCHEMBL18044580

SCHEMBL18044580

C[C@@H](c1ccccc1)n1cccc(C(=O)Nc2ccc(-c3cn(C4CCN(C)CC4)c4ncnc(N)c34)cc2)c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCK P08631 10/20 0.50
FLT3 P36888 9/20 0.50
AXL P30530 6/20 0.48
MERTK Q12866 2/20 0.48
RET P07949 2/20 0.48
SRC P12931 2/20 0.48
PLK4 O00444 1/20 0.48
DCLK1 O15075 1/20 0.48
PDPK1 O15530 1/20 0.48
PRKD3 O94806 1/20 0.48
MAP4K4 O95819 1/20 0.48
PAK4 O96013 1/20 0.48
CHEK2 O96017 1/20 0.48
ABL1 P00519 1/20 0.48
EGFR P00533 1/20 0.48
ERBB2 P04626 1/20 0.48
NTRK1 P04629 1/20 0.48
INSR P06213 1/20 0.48
LCK P06239 1/20 0.48
FYN P06241 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18044635 0.89 SRC (0.49) HCKFLT3AXLMERTKRET
SCHEMBL20335586 0.89 SRC (0.49) HCKFLT3AXLMERTKRET
SCHEMBL18044636 0.89 SRC (0.49) HCKFLT3AXLMERTKRET
SCHEMBL18044576 0.87 AXL (0.60) FLT3AXLMERTKRETSRC
SCHEMBL18044536 0.87 AXL (0.63) HCKFLT3AXLMERTKRET
SCHEMBL18044650 0.86 RET (0.55) HCKFLT3AXLMERTKRET
SCHEMBL18044672 0.85 AXL (0.49) HCKFLT3AXLMERTKRET
SCHEMBL18044573 0.84 RET (0.53) HCKFLT3AXLMERTKRET
SCHEMBL18044560 0.84 AXL (0.50) HCKFLT3AXLMERTKRET
SCHEMBL18044666 0.83 AXL (0.52) HCKFLT3AXLMERTKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067356-B1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-07-04 EP disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 US disclosed
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-09-15 US disclosed
EP-3067356-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE AXL, FLT3, TYRO3 HCK 514/4885FLT3 2/4885AXL 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.